Walleye Trading
CYTK icon

Walleye Trading’s Cytokinetics CYTK Stock Holding History

Walleye Trading’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.43M Sell
36,900
-200
-0.5% -$12.7K ﹤0.01% 1586
2025
Q4 		$2.36M Buy
37,100
+24,000
+183% +$1.49M ﹤0.01% 1793
2025
Q3 		$720K Sell
13,100
-58,800
-82% -$2.42M ﹤0.01% 2486
2025
Q2 		$2.38M Buy
71,900
+49,900
+227% +$1.74M ﹤0.01% 1632
2025
Q1 		$884K Buy
+22,000
New +$1.01M ﹤0.01% 2139
2024
Q2 		– Sell
-32,400
Closed -$2.27M – 4396
2024
Q1 		$2.27M Buy
32,400
+30,700
+1,806% +$2.37M ﹤0.01% 1657
2023
Q4 		$142K Sell
1,700
-14,900
-90% -$540K ﹤0.01% 3981
2023
Q3 		$489K Sell
16,600
-1,400
-8% -$46.6K ﹤0.01% 2979
2023
Q2 		$587K Buy
+18,000
New +$666K ﹤0.01% 2617
2023
Q1 		– Sell
-7,000
Closed -$321K – 4921
2022
Q4 		$321K Buy
7,000
+3,000
+75% +$129K ﹤0.01% 3186
2022
Q3 		$194K Sell
4,000
-4,700
-54% -$226K ﹤0.01% 3695
2022
Q2 		$342K Buy
+8,700
New +$350K ﹤0.01% 3290
2022
Q1 		– Sell
-5,000
Closed -$228K – 5423
2021
Q4 		$228K Buy
5,000
+4,900
+4,900% +$189K ﹤0.01% 3752
2021
Q3 		$4K Buy
+100
New +$2.94K ﹤0.01% 5082
2019
Q4 		– Sell
-17,100
Closed -$195K – 4307
2019
Q3 		$195K Sell
17,100
-4,900
-22% -$61.5K ﹤0.01% 2941
2019
Q2 		$248K Buy
+22,000
New +$212K ﹤0.01% 2771

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Walleye Trading's CYTK Position: Q1 2026 in Review

Walleye Trading sold out of Cytokinetics (CYTK) in Q1 2026, closing a stake of 16,658 shares — an estimated $1.06M sold.

Walleye Trading first reported a position in CYTK in Q3 2015 and held it in 11 quarters. The position peaked at $3.45M in Q4 2023. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Walleye Trading reported no remaining Cytokinetics position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 16,658 Cytokinetics shares in Q1 2026, an estimated $1.06M.
  • Walleye Trading first reported a position in Cytokinetics in Q3 2015 and held it in 11 quarters.
  • Walleye Trading's Cytokinetics position peaked at $3.45M in Q4 2023.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.